The Effect of Exercise in Patients Awaiting Bariatric Surgery
Launched by UNIVERSITY COLLEGE, LONDON · Feb 1, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a four-week exercise program can affect patients who are waiting for bariatric surgery, which is a type of weight-loss surgery. Researchers want to see if exercising before the surgery can improve fitness levels, metabolic rate (how quickly your body uses energy), and body weight, both before and after the surgery. The trial is taking place at several hospitals, including UCLH, and is currently looking for participants.
To join this study, you need to be an adult aged 18 or older and enrolled in a bariatric surgery program with a body mass index (BMI) over 30. It’s also important that your weight hasn’t changed significantly in the last three months, and you should be able to follow the study rules. If you decide to participate, you will take part in supervised exercise sessions and will have your fitness, weight, and strength measured before and after the program. Additionally, you may be asked about your experience in the study, which could help with future research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults, aged 18 and above.
- • 2. Patients enrolled in the UCLH, Homerton or Whittington Hospitals bariatric surgery program with BMI \> 30 kg/m2
- • 3. ≤5 % variation in body weight over preceding 3 months.
- • 4. Willing and able to comply with the trial protocol.
- • 5. Willing and able to provide written informed consent
- • 6. Male or Female
- Exclusion Criteria:
- • 1. Pregnant or lactating mothers.
- • 2. Weight over 180 kg (due to weight restrictions of equipment used).
- • 3. Current use of betablockade.
- • 4. Concurrent participation in other clinical intervention trial.
- • 5. Clinically significant medical co-morbidities (e.g. uncontrolled hypertension, unstable cardiovascular disease) that could place at risk of an adverse response to exercise.
- • 6. History of atrial fibrillation, unstable angina, acute coronary syndrome, congestive heart failure New York Heart Association class III-IV within the preceding 12 months.
About University College, London
University College London (UCL) is a leading global research institution renowned for its commitment to advancing healthcare through innovative clinical trials. As a prominent sponsor of clinical research, UCL leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous investigations aimed at improving patient outcomes and addressing pressing medical challenges. The institution fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring that its trials adhere to the highest ethical standards and regulatory guidelines. UCL's dedication to translating scientific discoveries into practical applications underscores its role as a vital contributor to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Belinda Durey
Principal Investigator
UCL, UniSA and UNSW
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials